SETS aHUS

SETS aHUS is funded by a grant from the NIHR’s HTA Programme to CI Neil Sheerin and team.

It is a multicentre clinical trial, using an open label, prospective and single arm design, with non-blinded assessment of the safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome.

You can find out more here, from SETS aHUS’s award page, or from it’s registration on ClinicalTrials.gov.